Long-Term Efficacy and Safety of Stapokibart in Adults with Moderate-to-Severe Atopic Dermatitis: An Open-Label Extension, Nonrandomized Clinical Trial

Yan Zhao(Peking University), Bin Yang(Southern Medical University), Yangfeng Ding(Shanghai Stomatological Hospital), Litao Zhang(Wuhan University), Qingchun Diao(Beijing University of Chinese Medicine), Xiujuan Xia(Qingdao University), Xiaohua Tao(Zhejiang Provincial People's Hospital), Xiaohong Zhu(First Affiliated Hospital of Wenzhou Medical University), Qianjin Lu(Central South University), Fuqiu Li(Second Affiliated Hospital of Jilin University), Yingmin Jia(Beijing Technology and Business University), Liming Wu(Hangzhou First People's Hospital), Xiao‐Yong Man(Second Affiliated Hospital of Zhejiang University), Jing Li(Unknown), Libo Zhang(Southern University of Science and Technology), Linfeng Li(Beijing Friendship Hospital), Bo Chen(Bioscience (China)), Chunlei Zhang(Guiyang College of Traditional Chinese Medicine), Yumei Li(Jilin University), Jinyan Wang(Ningbo No.6 Hospital), Jianyun Lu(Central South University), Jiao-Ran Song(Bioscience (China))
BioDrugs
July 31, 2024
Cited by 16


Related Papers